These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8725353

  • 21. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
    Cashman JD, Eaves AC, Eaves CJ.
    Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302
    [Abstract] [Full Text] [Related]

  • 22. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B, Broeders L, Touw I, Löwenberg B.
    Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
    [Abstract] [Full Text] [Related]

  • 23. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH, Talpaz M, Deisseroth AB, Estrov Z.
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [Abstract] [Full Text] [Related]

  • 24. Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells.
    Sato Y, Matsumori A, Sasayama S.
    J Mol Cell Cardiol; 1995 Oct; 27(10):2265-73. PubMed ID: 8576941
    [Abstract] [Full Text] [Related]

  • 25. Effect of recombinant human M-CSF on the proliferation of leukemic blast progenitors in AML patients.
    Suzuki T, Nagata K, Murohashi I, Nara N.
    Leukemia; 1988 Jun; 2(6):358-62. PubMed ID: 3287022
    [Abstract] [Full Text] [Related]

  • 26. Vesnarinone-induced granulocytopenia: incidence in Japan and recommendations for safety.
    Furusawa S, Ohashi Y, Asanoi H.
    J Clin Pharmacol; 1996 May; 36(5):477-81. PubMed ID: 8739027
    [Abstract] [Full Text] [Related]

  • 27. The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells.
    Bonnet D, Césaire R, Lemoine F, Aoudjhane M, Najman A, Guigon M.
    Exp Hematol; 1992 Feb; 20(2):251-5. PubMed ID: 1544396
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
    Nara N, Kurokawa H, Tohda S, Tomiyama J, Nagata K, Tanikawa S.
    Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture.
    Miyauchi J, Kelleher CA, Wong GG, Yang YC, Clark SC, Minkin S, Minden MD, McCulloch EA.
    Leukemia; 1988 Jun; 2(6):382-7. PubMed ID: 2453760
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M, Bergamaschi G, Dezza L, D'Uva R, Ponchio L, Rosti V, Ascari E.
    Cancer Res; 1991 Jan 15; 51(2):536-41. PubMed ID: 1985771
    [Abstract] [Full Text] [Related]

  • 37. Comparative effects of busulfan, cytosine arabinoside and adriamycin on different maturation stages of normal human bone marrow cells.
    Tohda S, Nagata K, Suzuki T, Nara N.
    Acta Haematol; 1990 Jan 15; 83(1):16-21. PubMed ID: 2105564
    [Abstract] [Full Text] [Related]

  • 38. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
    Lagneaux L, Marie JP, Delforge A, Socquet M, Thevenin D, Zittoun R, Stryckmans P.
    Exp Hematol; 1989 Aug 15; 17(7):843-6. PubMed ID: 2753092
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar 15; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.